News & Events

Applied Cells is pleased to announce the expansion of the MARS® Ingenuity™ line with the addition of CD34 Nanobeads, TCR α/β Nanobeads, and CD56 Nanobeads,

Santa Clara, California, and Bengaluru, India, January 13, 2026.  Applied Cells Inc. announced today  a strategic collaboration framework with Immuneel Therapeutics Private Limited to jointly

We’re excited to announce another significant milestone — Applied Cells has officially submitted a Type II Master File (MAF) for the MARS® Bar system to

We’re excited to share BIG NEWS — Applied Cells is now officially ISO 13485:2016 certified for the design and manufacture of sterile human cell separation

CAR-T cell therapies have shown great success in treating hematological cancers, including leukemia, lymphoma and multiple myeloma, by using genetically modified T cells to effectively

As we step into 2025, we are happy to announce that our study results were published in Cytotherapy journal. Co-authored with researchers from the University